Why Protocol Complexity Keeps Increasing – and How to Fix It
Despite genuine efforts across the industry to reduce protocol complexity, the trend line hasn't budged. The reasons are partly scientific and operational. And they're also deeply human.
Pfizer follows Moderna’s suit in releasing Covid-19 vaccine study protocol
Protocols - essentially the blueprints for clinical trials - are typically kept under wraps until studies are complete, but Pfizer and Moderna have made the ones for their SARS-CoV-2 trials public in a transparency push.
presented by
Survey on the Healthcare Financial Landscape Offers a Roadmap for Stakeholders
Zelis highlights how employers, payers, and consumers are integrating digital tools to manage healthcare costs.